Protections against the Risk of Airborne SARS-CoV-2 Infection

Código QR

Protections against the Risk of Airborne SARS-CoV-2 Infection

Guardado en:

Detalles Bibliográficos
Autor principal:	Clement J. McDonald
Formato:	article
Lenguaje:	EN
Publicado:	American Society for Microbiology 2020
Materias:	COVID-19 HEPA filters N95 respirator route of infection SARS-CoV-2 airborne microorganisms Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/ced2baa618164c79b1d7db8e7f20c44e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The Impact of Large Mobile Air Purifiers on Aerosol Concentration in Classrooms and the Reduction of Airborne Transmission of SARS-CoV-2
por: Finn F. Duill, et al.
Publicado: (2021)

Effectiveness of Face Masks in Preventing Airborne Transmission of SARS-CoV-2
por: Hiroshi Ueki, et al.
Publicado: (2020)

The vaccination threshold for SARS-CoV-2 depends on the indoor setting and room ventilation
por: A. Mikszewski, et al.
Publicado: (2021)

Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant
por: Ravi Kant, et al.
Publicado: (2021)

Can a Nasal/Oral/Ocular Spray Inactivate and Prevent SARS-CoV-2 infection? A hypothesis
por: Fuentes,Edgardo, et al.
Publicado: (2020)

Microwave-Generated Steam Decontamination of N95 Respirators Utilizing Universally Accessible Materials
por: Katelyn E. Zulauf, et al.
Publicado: (2020)

Evaluation of Residual Infectivity after SARS-CoV-2 Aerosol Transmission in a Controlled Laboratory Setting
por: Luisa Zupin, et al.
Publicado: (2021)

Characterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity
por: Haijun Tang, et al.
Publicado: (2021)

Corrigendum: Characterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity
por: Haijun Tang, et al.
Publicado: (2021)

Detection of Antibodies Against the SARS-CoV-2 Spike Protein and Analysis of the Peripheral Blood Mononuclear Cell Transcriptomic Profile, 15 Years After Recovery From SARS
por: Lili Zhao, et al.
Publicado: (2021)

La Saliva como Biomuestra para Diagnóstico de Infección por SARS-CoV-2: Una Revisión
por: Morales-Espinosa,Rolando
Publicado: (2020)

Assessing SARS-CoV-2 Vertical Transmission and Neonatal Complications
por: Cosmin Citu, et al.
Publicado: (2021)

Weekly SARS-CoV-2 screening of asymptomatic kindergarten to grade 12 students and staff helps inform strategies for safer in-person learning
por: Shira Doron, et al.
Publicado: (2021)

Effective Prophylaxis of COVID-19 in Rhesus Macaques Using a Combination of Two Parenterally-Administered SARS-CoV-2 Neutralizing Antibodies
por: Brandon J. Beddingfield, et al.
Publicado: (2021)

Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine
por: Taweewun Hunsawong, et al.
Publicado: (2021)

Pandemia SARS-CoV-2 y embarazo en el Hospital el Pino: un estudio descriptivo
por: Morales M.,Nereida, et al.
Publicado: (2020)

Can Science Help Resolve the Controversy on the Origins of the SARS-CoV-2 Pandemic?
por: Arturo Casadevall, et al.
Publicado: (2021)

SARS-CoV-2 Prevalence in Laparoscopic Surgery Filters. Analysis in Patients with Negative Oropharyngeal RT-qPCR in a Pandemic Context: A Cross-Sectional Study
por: Antoni Llueca, et al.
Publicado: (2021)

Assessment of COVID-19 Incidence and the Ability to Synthesise Anti-SARS-CoV-2 Antibodies of Paediatric Patients with Primary Immunodeficiency
por: Karolina Pieniawska-Śmiech, et al.
Publicado: (2021)

Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in <i>Nicotiana benthamiana</i> Plant as a Vaccine Candidate against COVID-19
por: Tarlan Mamedov, et al.
Publicado: (2021)

Telehealth in the times of SARS-CoV-2 infection for the otolaryngologist
por: Victoria W. Huang, et al.
Publicado: (2020)

Can the SARS-CoV-2 Spike Protein Bind Integrins Independent of the RGD Sequence?
por: Christopher A. Beaudoin, et al.
Publicado: (2021)

COVID-19 Breakthrough Infections and Transmission Risk: Real-World Data Analyses from Germany’s Largest Public Health Department (Cologne)
por: Lea Hsu, et al.
Publicado: (2021)

The effect of eye protection on SARS-CoV-2 transmission: a systematic review
por: Oyungerel Byambasuren, et al.
Publicado: (2021)

Vaccinated Patients Admitted in ICU with Severe Pneumonia Due to SARS-CoV-2: A Multicenter Pilot Study
por: Ángel Estella, et al.
Publicado: (2021)

Current Potential Therapeutic Approaches against SARS-CoV-2: A Review
por: Dharmendra Kumar Yadav, et al.
Publicado: (2021)

Persistence of the SARS-CoV-2 Antibody Response in Asymptomatic Patients in Correctional Facilities
por: Xiaodong Tian, et al.
Publicado: (2021)

SARS-CoV-2 en atención odontológica: vías de transmisión y sus consideraciones en la práctica clínica
por: Cruzat Villalobos,Gilena, et al.
Publicado: (2020)

An Observational Study on Patients with Acute Limb Ischemia and SARS-CoV-2 Infection: Early and Late Results in Limb Salvage Rate
por: Sorin Barac, et al.
Publicado: (2021)

The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19
por: Kun Li, et al.
Publicado: (2021)

The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity
por: Carlos del Fresno, et al.
Publicado: (2021)

Development of an Inactivated Vaccine against SARS CoV-2
por: Shaikh Terkis Islam Pavel, et al.
Publicado: (2021)

In-Depth Longitudinal Comparison of Clinical Specimens to Detect SARS-CoV-2
por: Justine Defêche, et al.
Publicado: (2021)

SARS-CoV-2 and Public Transport in Italy
por: Giuseppina Caggiano, et al.
Publicado: (2021)

SARS-CoV-2 Modelo de Inoculación en la Cavidad Oral. Revisión de la Literatura
por: Villanueva-Sánchez,Francisco Germán, et al.
Publicado: (2020)

CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated Immunopathology
por: Jennifer K. DeMarco, et al.
Publicado: (2021)

SARS‐CoV‐2 infection shortly after BNT162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff
por: Doris Urlaub, et al.
Publicado: (2021)

Decontamination Methods of N95 Respirators Contaminated with SARS-CoV-2
por: Thirumaaran Gopalan, et al.
Publicado: (2021)

Neutralizing antibody response to SARS-CoV-2 persists 9 months post symptom onset in mild and asymptomatic patients
por: Olivier Bylicki, et al.
Publicado: (2021)

Mouthwashes and Nasal Sprays as a Way to Prevent the Spread of SARS-CoV-2
por: Santos-López,Matías, et al.
Publicado: (2020)